Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9247

This is a table containing information about the number of patients and their treatment groups based on cumulative doses of Doxorubicin. The number of patients is 120 and the treatment groups include FAG/Dexrazoxane and FAC. The cumulative dose of Doxorubicin ranges from 350 to 1000+ mg/m².*

Dexrazoxane is a pyrogen-free, sterile lyophilizate available in single-dose vials for intravenous usage only. No further information is available.*

This text provides product identification information in the form of TwoD (2D) barcodes on packaging. The first set of characters represents a lot number, followed by a five-character alphanumeric code, which could represent a product code or lot control number. Below that, there is an expiration date represented by the letters "EXP," followed by a three-letter abbreviation for the month and a four-digit year. Finally, there is a Global Trade Item Number (GTIN), which is a unique identifier for a product. The last line of text contains a serial number specific to this individual product. This information could be valuable for tracking products through the supply chain or identifying specific items in a recall.*

This is a description of a medication called Dexrazoxane for injection. It is administered intravenously and is indicated for specific indications. The packaging is sterile, pyrogen-free, and marked by a unique product code (NDCOM9248-01). It may also contain WYOPHILZATE, although the use of this component is unclear. The rest of the text contains unclear or unreadable characters.*

This appears to be a product label or packaging information with a GTIN (Global Trade Item Number), a SN (Serial Number), an EXP (Expiration Date) in the format of MMMYYYY, and a LOT (Lot Number) of ABCDE12345. It may be used for inventory management, traceability, and quality management purposes.*